FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB3 days ago · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower ...
FTC sues pharmacy benefit managers for inflating price of …
WEB1 day ago · The three PBMs named in the FTC lawsuit make up about 80% of the market. According to the suit, the PBMs collected billions of dollars in rebates and fees while insulin became increasingly ...
High insulin prices spur a federal lawsuit against three pharmacy ...
WEB2 days ago · Updated 1:40 PM PDT, September 20, 2024. The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients. Three companies that process about 80% of prescriptions in the United States — Caremark, Express …
FTC sues drug 'gatekeepers' over high insulin prices - USA TODAY
WEB3 days ago · 0:04. 1:12. The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients toward higher-priced insulin to reap ...
Feds sue pharmacy gatekeepers over high insulin costs
WEB3 days ago · Updated: 09/20/2024 03:21 PM EDT. The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug prices on behalf of insurers, claiming ...
FTC Releases Interim Staff Report on Prescription Drug Middlemen
WEBThe Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs.
FTC Further Expands Inquiry Into Prescription Drug Middlemen …
WEBJun 8, 2023 · As part of its ongoing study on pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issued a compulsory order to a third group purchasing organization (GPO) that negotiates drug rebates on behalf of PBMs.
F.T.C. Slams Middlemen for High Drug Prices - The New York Times
WEBJul 9, 2024 · The Federal Trade Commission on Tuesday sharply criticized pharmacy benefit managers, saying in a scathing 71-page report that “these powerful middlemen may be profiting by inflating drug...
Federal Trade Commission sues Express Scripts, Caremark Rx and …
WEB7 hours ago · The three pharmacy benefit managers (PBMs), which the FTC said administer about 80% of all prescriptions in the U.S., created a “perverse drug rebate system” that prioritizes high rebates from ...
Big Pharmacy-Benefit Managers Increase Drug Costs, FTC Says
WEBJul 9, 2024 · Investigation finds firms, which are supposed to control spending, have overcharged for cancer drugs and taken other steps raising costs. The Federal Trade Commission launched its...